By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Paris, France
April 16, 2026
  • English
    • Nederlands (Dutch)
    • Français (French)
    • Deutsch (German)
    • Italiano (Italian)
    • Polski (Polish)
    • Español (Spanish)
    • Türkçe (Turkish)
    • Українська (Ukrainian)
  • About Us
  • Contact Us
  • Submit News
Paris
+22°C

High: +22°

Low: +13°

Sat, 13.07.2024
EU Newsroom™
Submit News
  • Automotive
  • Business
  • Energy
  • Finance
  • Healthcare
  • Lifestyle
  • Politics
  • Real Estate
  • Sports
  • Technology
  • Travel
  • News
    • EU
    • Europe
    • Press Releases
Reading: Organoids Market to Reach USD 2.82 billion by 2030, Driven by Rising Use in Drug Discovery and Personalized Medicine
Share
EU Newsroom™EU Newsroom™
Font ResizerAa
Search
  • English
    • Nederlands (Dutch)
    • Français (French)
    • Deutsch (German)
    • Italiano (Italian)
    • Polski (Polish)
    • Español (Spanish)
    • Türkçe (Turkish)
    • Українська (Ukrainian)
  • Automotive
  • Business
  • Energy
  • Finance
  • Healthcare
  • Lifestyle
  • Politics
  • Real Estate
  • Sports
  • Technology
  • Travel
  • News
    • EU
    • Europe
    • Press Releases
  • About Us
  • Contact Us
  • Submit News
EU Newsroom™ is part of GroupWeb Media Network. © 2024 GroupWeb Media LLC
EU Newsroom™ > Press Releases > Organoids Market to Reach USD 2.82 billion by 2030, Driven by Rising Use in Drug Discovery and Personalized Medicine
Press ReleasesPress Releases

Organoids Market to Reach USD 2.82 billion by 2030, Driven by Rising Use in Drug Discovery and Personalized Medicine

EU Newsroom
Last updated: December 26, 2025 8:15 pm
EU Newsroom 4 months ago
Share
Share


Introduction 

The organoids market is gaining strong attention within life sciences and biomedical research as three-dimensional cell culture models become essential tools for understanding human biology. According to Mordor Intelligence, The organoids market size is USD 1.20 billion in 2025 and is forecast to reach USD 2.82 billion by 2030, reflecting an 18.60% CAGR. This growth reflects increasing reliance on organoid-based models for disease modeling, drug screening, and translational research, particularly where traditional two-dimensional cultures and animal models show limitations. 

Organoids are miniature, lab-grown structures that replicate the architecture and function of human organs. Their ability to closely mimic real human tissue has positioned them as valuable research tools across pharmaceutical development, cancer studies, and regenerative medicine. As research institutions and biotechnology companies seek more predictive and human-relevant platforms, organoids are steadily becoming a preferred choice. 

Key Trends in Organoids Market 

Growing Use in Drug Discovery and Toxicity Testing 

One of the most notable organoids market trends is the increasing application of organoids in drug discovery workflows. Pharmaceutical companies are adopting organoids to evaluate drug efficacy and safety earlier in development. These models offer more accurate insights into human responses compared to conventional cell cultures, helping reduce late-stage drug failures. 

Expansion of Personalized Medicine Applications 

Personalized medicine continues to influence the direction of the organoids market. Patient-derived organoids enable researchers to test treatment responses using tissue that reflects individual genetic and molecular profiles. This approach is especially relevant in oncology, where tumor organoids help guide therapy selection and improve clinical decision-making. 

Rising Adoption in Academic and Translational Research 

Academic institutions remain key contributors to organoid research, using these models to study organ development, genetic disorders, and infectious diseases. Translational research programs are also expanding their use of organoids to bridge laboratory findings with clinical outcomes. This sustained academic involvement supports steady demand across multiple organoid types. 

Organoids Market Segmentation 

The organoids market analysis segments the industry based on type, application, end user, and geography, each reflecting distinct adoption patterns. 

By Type 

  • Stem-cell-derived Organoids 
  • Tumor-derived Organoids 

By Application 

  • Drug Discovery & Screening 
  • Disease & Toxicology Modelling 
  • Precision & Personalised Medicine 
  • Regenerative Medicine 
  • Others (e.g., Gene-editing Validation) 

By End User 

  • Pharmaceutical & Biotech Companies 
  • Academic & Research Institutes 
  • CROs & CDMOs 
  • Hospitals & Diagnostic Laboratories 

By Technology 

  • Scaffold-based 3D Culture 
  • Scaffold-free / Suspension Culture 
  • Microfluidic / Organ-on-chip-integrated Systems 
  • 3D Bioprinting-assisted Organoids 

By Geography 

  • North America 
  • South Amerca 
  • Middle east&Africa 
  • Europe 
  • Asia pacific 

This segmentation highlights how diverse use cases contribute to the overall organoids market size while supporting balanced growth across sectors. 

Key Players 

The organoids market includes a mix of biotechnology companies, reagent suppliers, and specialized research solution providers. These players focus on developing organoid culture systems, matrices, growth media, and related services tailored to specific research needs. 

  • Merck KGaA 
  • Cellesce Ltd 
  • 3Dnamics Inc. 
  • R&D Systems, Inc. 
  • Hubrecht Organoid Technology 

As competition intensifies, companies are emphasizing quality, consistency, and application-specific support to maintain and grow their organoids market share. 

Conclusion 

The organoids market is set to maintain steady expansion as demand rises for research models that better reflect human biology. The growing focus on drug discovery efficiency, personalized medicine, and disease-specific research continues to support adoption across both commercial and academic settings. 

Future organoids market growth will depend on continued validation of organoids as reliable research tools and their integration into standard development workflows. While challenges such as standardization and scalability remain, ongoing collaboration between researchers, clinicians, and industry players is expected to address these concerns. 

Industry related Reports: 

Cell Culture Market: The Cell Culture Market Report is Segmented by Product (Equipment and Consumables), Cell Type (Mammalian Cells, and More), Technology (2-D Cell Culture and 3-D Cell Culture), Application (Biopharmaceutical Production, Drug Discovery & Development, and More), End-User (Pharmaceutical & Biotechnology Companies, and More), and Geography (North America, Europe, and More). 

Biotechnology Market: Biotechnology Market Report Segments the Industry Into by Technology (DNA Sequencing, Nanobiotechnology and More), Application (Health & Red Biotechnology, Food and Agriculture and More), End User (Biopharma & Biotechnology Companies, Cmos & CROs and More), Product Type (Biopharmaceuticals, Bioprocess Equipment & Consumables and More), and Geography. 

Biopreservation Market: The Biopreservation Market Report is Segmented by Product Type (Biopreservation Media and Equipment [Temperature-Maintaining Units, Consumables and More), Biospecimen ( Human Tissues and More), Preservation Method (Cryopreservation, Vitrification and More), Application Area (Biobanking and More), End User (Biobanks & Gene Banks, and More), and Geography. 

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. 

For any inquiries or to access the full report, please contact: 

media@mordorintelligence.com
https://www.mordorintelligence.com/ 



Source link

You Might Also Like

Agoraphobia Market is expected to Reach USD 3.05 Billion by 2030 at a CAGR of 7.35 percent

Zero Trust Security Market Classification, Application, Industry Overview, And Competitive Landscape To 2030

The Middle East and Africa Silk Market is projected to reach a market size of USD 1.51 billion by the end of 2030

The Zircon Sand Market is expected to grow USD 3.99 Bn by 2030, as per Maximize Market Research.

Armored Vehicles Market Size to Reach USD 42.18 Billion by 2031 Amid Rising Defense Procurement and Hybrid Propulsion Adoption- Mordor Intelligence

العلامات :Organoids Market AnalysisOrganoids Market GrowthOrganoids Market ShareOrganoids Market Size
Share This Article
Facebook Twitter Whatsapp Whatsapp LinkedIn Email Print
Previous Article Personalized Nutrition Market to Reach USD 31.89 billion by 2030, Supported by Data-Driven Diet Planning and Preventive Health Focus
Next Article Naval Vessel Defense Systems Market to Reach USD 24.32 billion by 2030 – Mordor Intelligence

Share Us

Popular News
Press ReleasesPress Releases

Greek Yogurt Market to Hit USD 21.67 Bn at a CAGR of 8.71 percent during the forecast period

EU Newsroom By EU Newsroom 2 years ago
Global Testing, Inspection & Certification services for Telecommunication Sector Market is projected to reach the value of $333.07 Billion by 2030
Europe’s Auto Industry Faces Chinese Competition And Challenge In Transition To EVs
Drug Repurposing Market Growth Fueled by Robust R&D, Biologics, and Disease-Centric Segments Research as per Maximize Research
Predictive Maintenance Market Size: 2024 Global Industry Trends, Growth, Share To 2030

EUROPENEWSWIRE.NET

The no.1 press release distribution to media in Europe.

Submit News
About Us

EU Newsroom™ publishes and distributes news about the European Union with focus on Automotive, Business, Energy, Finance, Healthcare, Lifestyle, Politics, Real Estate, Sports, Technology, Travel. This news is published and distributed in German, French, English, Turkish, Italian, Spanish, Polish, Ukrainian, Dutch – some of the languages used in the EU.

EU Newsroom™, in association with EuropeNewswire.Net™ also publishes and distributes press releases newsrooms and media outlets throughout Europe. For press release distribution to newsrooms in EU.

Contact Us
  • +1 832-716-2363
  • Skype: groupwebmedia
  • Telegram: @groupwebmedia
Categories

Automotive
Business
Energy
Finance
Healthcare
Lifestyle
Politics
Real Estate
Sports
Technology
Travel
News
EU
Europe
Press Releases

Recent News
$128.6 Billion by 2032 — Standalone Headsets Lead the VR Gaming Explosion
22 hours ago
$22.4 Billion by 2032 — Why the 32-Inch Format Dominates Smart Homes & Industrial HMIs
22 hours ago
$168.5 Billion by 2032 — Unified Commerce Drives the Next-Generation POS Revolution
22 hours ago
$9.8 Billion by 2032 — How Automated Vehicle Barriers Are Reshaping Perimeter Security
22 hours ago
  • English
  • Nederlands (Dutch)
  • Français (French)
  • Deutsch (German)
  • Italiano (Italian)
  • Polski (Polish)
  • Español (Spanish)
  • Türkçe (Turkish)
  • Українська (Ukrainian)
EU Newsroom™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC
  • About Us
  • Contact Us
  • Submit News
Welcome Back!

Sign in to your account

Lost your password?